top of page

                     

       

        Arstat Pharmaceuticals is preparing for a Q1 2027 Nasdaq

  listing. We provide investor materials to qualified partners who  align with our long‑term vision and the scale of the opportunity.
 

Investment Overview (Summary Graphic)


To request information regarding Arstat Pharmaceuticals investment opportunity, please contact:
 

 Arkady Rubin, PhD, Founder, President / CSO

Email: arubin@arstatinc.com

Phone: (347)385-0878

Thanks for submitting!

bottom of page